Results 101 to 110 of about 26,226 (199)

DataSheet1_Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023).docx

Background: Thromboembolic disease is associated with a high rate of disability or death and gravely jeopardizes people’s health and places considerable financial pressure on society.
Xingyue Zheng (17749752), Lizhu Han (12062840), Yin Wang (34938), Shuhong Liang (690051), Fengjiao Kang (18134812), Yong Yang (63842), Qinan Yin (8897771), Lian Li (49049), Yuan Bian (701737), Min Chen (147733), Li e Dong (18134818), Fengqun Cai (18134815), Liuyun Wu (17057316), Limei Dong (9617966)   +13 more
core   +1 more source

Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins

Haematologica, 2003
During the last decade, new anticoagulant drugs with anti-factor-Xa properties have been described (1, 2). Among them is fondaparinux that has been licensed recently. It is a pentasaccharide mimicking the site where heparin binds to antithrombin III (1).
R Parody, A Oliver, JC Souto, J Fontcuberta   +3 more
doaj  

A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy.

, 2015
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During ...
De Stefano, Valerio, Buonomo, Alessandro, De Carolis, Sara, Di Pasquo, Elvira, Nucera, Eleonora, Pascolini, Lucilla, Betti, Silvia, Schiavino, Domenico   +7 more
core  

Functional characterization of a 3-O-sulfate tolerant heparin lyase from Bacteroides eggerthii. [PDF]

Glycobiology
Kandola TK, Mycroft-West CJ, Lima MA, Turner A, Gardini C, Urso E, Torode TA, Miller GJ, Bisio A, Yates EA, Guerrini M, Skidmore MA, Wu L.   +12 more
europepmc   +1 more source

Profound thrombocytopenia and transient leucoerythroblastosis following hip fracture surgery. [PDF]

BMJ Case Rep
Eshaghpour A, Bell C, Nazy I, Warkentin TE.   +3 more
europepmc   +1 more source

Anticoagulants, Their Laboratory Monitoring, and Reversal. [PDF]

Hematol Rep
Barouqa M, Yassa ME, Dela Cruz N, Babker M.   +3 more
europepmc   +1 more source

Clinical pharmacist-guided management of heparin-induced thrombocytopenia with thrombosis after hip hemiarthroplasty: a case report. [PDF]

Front Cardiovasc Med
Yin Q, Han L, Bian Y, Song Y, Huang Y.
europepmc   +1 more source

PERBANDINGAN KUALITAS HIDUP PENDERITA SINDROMA KORONER AKUT DENGAN TERAPI HEPARIN DAN FONDAPARINUX

, 2013
Anticoagulant therapy (heparin or fondaparinux) is applied to prevent the the extendibility of the thrombus and to avoid death in acute coronary syndrome (ACS). From other research fondaparinux has better efficacy and more safety than heparin. Heparin is
, KUSUMAWARDHANI ANDANASARI, , Ika Puspita Sari, M.Si., Ph.D., Apt.   +1 more
core  

The anticoagulation dilemma: A case report of pulmonary embolism in a gastric cancer patient with concurrent gastrointestinal bleeding and thrombocytopenia. [PDF]

Medicine (Baltimore)
Yun X, Wang T, Dong C, Yang W, Zhuang X, Zeng C, Huang S, Yao D.   +7 more
europepmc   +1 more source

Anticoagulation Monitoring in Recurrent Venous Thromboembolism Associated With Antiphospholipid Antibodies and Subsequent Heparin-Induced Thrombocytopenia. [PDF]

Cureus
Bechir G.
europepmc   +1 more source